rehabilitation needs of patients with multiple myeloma undergoing car-t therapy
Published 1 year ago • 109 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
1:12
optimizing car-t therapy for patients with multiple myeloma in the real-world
-
1:47
clinical outcomes of patients with r/r multiple myeloma listed for treatment with car-t therapy
-
2:00
the value of car-t cell therapy for the treatment of r/r multiple myeloma
-
1:12
remission of multiple myeloma with car t-cell therapy
-
4:14
challenges with the real-world use of car-t therapy in multiple myeloma
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
3:25
belantamab mafodotin and its place in myeloma treatment
-
3:48
abecma car t-cell therapy for multiple myeloma
-
2:57
strategies to optimize car-t therapy in myeloma: bringing car-t into earlier lines
-
2:30
an update on the current status of car-t therapy in multiple myeloma
-
1:01
the potentially curative role of car-t therapy in myeloma
-
1:06
moving car-t therapy to earlier lines in multiple myeloma and clinical trials in this space
-
2:46
managing patients with high-risk myeloma
-
1:38
real world use of car t-cell therapy in multiple myeloma
-
4:02
moving car-t therapy into earlier lines of treatment for myeloma and the need for effective bridging
-
1:38
how to optimize access to car-t cell therapies in multiple myeloma
-
2:07
challenges with the preparation and administration of car-t therapy
-
2:40
car t-cell therapy to revolutionize multiple myeloma?
-
1:30
advances in immunotherapy for multiple myeloma
-
2:10
session highlights: clinical indications for car-t therapy in multiple myeloma
-
2:33
predicting response to car-t therapy with multi-omic approaches
-
1:22
the potential use of car-t therapy following autologous transplantation in multiple myeloma